LONDON and CAMBRIDGE, MA, Jul 21, 2008 (MARKET WIRE via COMTEX) -- InforSense Ltd., the leader in next generation business and scientific intelligence, today announced it has been listed by Gartner, Inc. in its Hype Cycle report for Healthcare Provider Applications and Systems(1). In the report Gartner defined a new category called Advanced Clinical Research Information Systems where InforSense is cited as a sample vendor.
"Products like Advanced Clinical Research Information Systems... are considered to have 'warm' profiles that have high value to care delivery organizations during the next two to five years," said the analysts in the report. "These products enable new ways of doing business and could result in cost savings or increased revenue."
According to the Gartner report, "An advanced clinical research information system (ACRIS) is a complex constellation of capabilities that can rapidly assemble data assets for research questions, and provide data mining and research process support to meet the needs of clinical and translational research and related biostatistics and biocomputation."
"We see significant market need for clinical and translational research intelligence solutions and we see the tremendous business impact they can have," said Jonathan Sheldon, Chief Scientific Officer at InforSense. "The initial implementations of our Translational Research Solution have been at academic research organizations seeking to quickly and easily aggregate clinical, sample and experimental data to discover hidden patterns and insights in diverse data sets. However, we are also receiving considerable interest now from Pharma and Biotech customers who are looking for new ways to integrate and analyse their translational data."
The Gartner report states, "The demand of ACRIS is triggered by two forces: increased adoption of commercial computer-based patient records and the rapidly advancing interest and funding for genomics and translational research." Moreover, "the competitive nature of clinical research will fuel the adoption speed, and grant awards will fuel investment."
The InforSense Translational Research Solution provides out-of-the-box tools and capabilities to integrate basic scientific research data and techniques with clinical research to improve disease understanding and patient care. World class healthcare institutions such as Erasmus University Medical Center and Dana-Farber Cancer Institute are using the InforSense solution in their translational research.
About InforSense
InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.
